Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3076
Ziff Davis
ZD
$1.7B
| $927K | ﹤0.01% |
16,359
+4,144
| +34% | +$227K |
2013 Q2
53 quarters
|
|
3077
First Community Corp
FCCO
$307M
| $926K | ﹤0.01% |
28,796
+1,698
| +6% | +$56.9K |
2020 Q2
25 quarters
|
|
3078
Kyverna Therapeutics
KYTX
$317M
| $926K | ﹤0.01% |
136,134
+18,290
| +16% | +$144K |
2024 Q1
10 quarters
|
|
3079
Bank of N.T. Butterfield & Son
NTB
$2.24B
| $924K | ﹤0.01% |
15,973
+10,341
| +184% | +$625K |
2017 Q1
38 quarters
|
|
3080
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.47B
| $923K | ﹤0.01% |
22,554
-332,740
| -94% | -$14.7M |
2019 Q4
27 quarters
|
|
3081
Amentum Holdings
AMTM
$5.56B
| $921K | ﹤0.01% |
50,809
-100,971
| -67% | -$2.11M |
2024 Q3
8 quarters
|
|
3082
PUT
Edison International
EIX
$23.1B
| $919K | ﹤0.01% |
+17,100
| New | +$1.16M |
2026 Q3
0 quarters
|
|
3083
Select Water Solutions
WTTR
$2.17B
| $918K | ﹤0.01% |
46,407
+13,020
| +39% | +$259K |
2017 Q2
37 quarters
|
|
3084
PUT
American Tower
AMT
$88.2B
| $917K | ﹤0.01% |
+5,600
| New | +$961K |
2026 Q3
0 quarters
|
|
3085
Peoples Bancorp
PEBO
$1.38B
| $917K | ﹤0.01% |
25,049
+154
| +0.6% | +$6.13K |
2016 Q1
42 quarters
|
|
3086
Rapport Therapeutics
RAPP
$1.6B
| $916K | ﹤0.01% |
27,271
+12,277
| +82% | +$530K |
2024 Q2
9 quarters
|
|
3087
uniQure
QURE
$1.72B
| $915K | ﹤0.01% |
37,893
+20,027
| +112% | +$869K |
2020 Q2
25 quarters
|
|
3088
PUT
Walmart Inc
WMT
$997B
| $914K | ﹤0.01% |
8,800
-1,883,300
| -100% | -$207M |
2024 Q3
8 quarters
|
|
3089
Atea Pharmaceuticals
AVIR
$338M
| $914K | ﹤0.01% |
175,465
-173,188
| -50% | -$886K |
2022 Q1
18 quarters
|
|
3090
CALL
Tango Therapeutics
TNGX
$4.36B
| $913K | ﹤0.01% |
+36,600
| New | +$953K |
2026 Q3
0 quarters
|
|
3091
PUT
Regeneron Pharmaceuticals
REGN
$99.2B
| $910K | ﹤0.01% |
+1,200
| New | +$907K |
2026 Q3
0 quarters
|
|
3092
Marcus & Millichap
MMI
$942M
| $907K | ﹤0.01% |
31,892
-7,385
| -19% | -$230K |
2016 Q3
40 quarters
|
|
3093
DELISTED
Weave Communications
WEAV
| $906K | ﹤0.01% |
122,757
-344,408
| -74% | -$2.37M |
2022 Q1
18 quarters
|
|
3094
Goosehead Insurance
GSHD
$1.1B
| $905K | ﹤0.01% |
19,952
-3,571
| -15% | -$213K |
2018 Q2
33 quarters
|
|
3095
Esquire Financial Holdings
ESQ
$1.61B
| $903K | ﹤0.01% |
7,764
-6,240
| -45% | -$758K |
2022 Q2
17 quarters
|
|
3096
Regenxbio
RGNX
$560M
| $902K | ﹤0.01% |
119,810
+75,743
| +172% | +$769K |
2016 Q3
40 quarters
|
|
3097
QCR Holdings
QCRH
$1.69B
| $902K | ﹤0.01% |
9,213
-1,499
| -14% | -$151K |
2015 Q2
45 quarters
|
|
3098
Dole
DOLE
$1.34B
| $901K | ﹤0.01% |
70,856
+56,475
| +393% | +$771K |
2022 Q1
18 quarters
|
|
3099
FS Bancorp
FSBW
$339M
| $898K | ﹤0.01% |
20,754
+1,692
| +9% | +$73.4K |
2017 Q4
35 quarters
|
|
3100
CorVel
CRVL
$4.24B
| $898K | ﹤0.01% |
12,049
+6,914
| +135% | +$458K |
2013 Q2
53 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.